Company Filing History:
Years Active: 1998-2016
Title: Innovations of Richard Cushman Orahood
Introduction
Richard Cushman Orahood is a notable inventor based in Delaware, Ohio. He has made significant contributions to the field of radiolabeling, particularly with his innovative compositions for diethylenetriaminepentaacetic acid (DTPA)-dextran. With a total of three patents to his name, Orahood's work has implications for medical applications and clinical practices.
Latest Patents
One of Orahood's latest patents focuses on compositions for radiolabeling DTPA-dextran with Technetium-99m. This invention aims to stabilize the DTPA-dextran Cold Kit and includes components such as Stannous Chloride ions, Ascorbic Acid, α,α-Trehalose, and Glycine. These ingredients work together to maintain a reducing environment and facilitate high radiochemical purity during the radiolabeling process. The invention also introduces a Diluent vial that adjusts the pH to a moderately acidic level, which enhances the ease of use for clinical practitioners and reduces pain during injection.
Career Highlights
Throughout his career, Orahood has worked with prominent companies in the biopharmaceutical sector, including Navidea Biopharmaceuticals, Inc. and Neoprobe Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for medical applications.
Collaborations
Orahood has collaborated with notable colleagues such as Gerald Ross Magneson and Marlin O Thurston. These partnerships have likely enriched his work and expanded the impact of his inventions.
Conclusion
Richard Cushman Orahood's contributions to the field of radiolabeling and his innovative patents demonstrate his commitment to advancing medical technology. His work continues to influence clinical practices and improve patient care.